|Bid||24.81 x 1200|
|Ask||24.82 x 800|
|Day's Range||24.75 - 24.89|
|52 Week Range||18.97 - 24.90|
|Beta (5Y Monthly)||1.04|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 01, 2022 - Nov 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||27.03|
Subscribe to Yahoo Finance Plus to view Fair Value for CHNG
In this article we present the list of 10 Stocks That Account for 90.88% of Varenne Capital’s 13F Portfolio. Click to skip ahead and see The 5 Stocks That Account for 78.95% of Varenne Capital’s 13F Portfolio. Guiseppe Perrone and Marco Sormani’s Varenne Capital Partners is a Paris, France-based investment firm that was co-founded by Perrone, […]
Change Healthcare's (CHNG) fiscal first-quarter 2023 results benefit from solid performance across Software and Analytics, Network Solutions and Enterprise Imaging segments.
Change Healthcare (CHNG) delivered earnings and revenue surprises of -2.56% and 0.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?